amgen meritade glp-1 activity duration Monthly weight loss drug helps people lose 20% of body weight, trial finds Amgen's obesity drug may help

HRT decisions at goal weight depend on whether you still need hormonal support

The purported health benefits now appear to be even more far-reaching, with the latest data from a trial called Select, published in 2023, showing that semaglutide can slash the risk of heart attacks and strokes by a fifth in patients with an existing history of cardiovascular disease

It focuses on counting servings rather than calories with a balance of lean proteins, vegetables, and healthy fats

Cochrane Database Syst Rev (2011) 2011(10):Cd006423

Drawing to the "25" line on a U-40 syringe gives you 0.625 mL instead of the 0.25 mL you expected, a 2.5x overdose